Royalty Pharma pays startup $525M for stake in Sanofi MS drug
10 May 2024 //
BIOPHARMADIVE
ImmuNext`s Biologic Enbrel (etanercept) Receives Approval in the U.S.
18 Oct 2023 //
FDA
Amgen has delayed the entry of another Enbrel biosimilar
02 Dec 2021 //
FIERCEPHARMA
Genentech v. Immunex, Genentech v. Amgen, Janssen v. Celltrion
06 Feb 2020 //
BIGMOLECULEWATCH